Related Articles

Brand Name Analysis
Drug Experts
Drug Labeling 1
Drug Labeling 2
Drug Labeling 3
Drug Labeling 4
Drug Name Review
Drug Packaging
Drug Packaging 2
Drug Safety
Drug Safety 2
Effect Analysis
FDA Report
FMEA
FMEA
Generic Drugs
Health Canada Report
Health Canada Report
Look Alike
Medication Safety
Medication Error
Medication Error
Post-marketing Risk Assessment
Risk Minimization
Safe Medication Practices
Stigmatized Diseases

More Articles


   To Receive our
   Newsletters please
   enter your Email:


     

DRUG LABELING

Officials debate giving FDA more power over drug labeling

The recent Vioxx scandal has started a whole new debate on the powers of the FDA. Officials are considering whether to give the FDA more authority over drug labeling or to revamp the entire system. At present, the FDA does not have the authority to request any specific changes on drug labels. They must work with the drug manufacturer to come up with something that is acceptable to both parties.


  Related Links

  - FDA
  - FDA MedWatch
  - FDA (AERS)
  - USP
  - Health Canada
  - EMEA
  - NCC MERP
 

   
 
     
     
  Home  |  About Us  |  Proprietary Naming  |  NonProprietary Naming  |  Labeling & Packaging  |  Risk Management  |   News  |  Contact Us
  Copyright © 2005 Drug Safety Institute. All Rights Reserved.